# Xenon MRI and Progressive ILD

> **NCT05241275** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Duke University** · enrollment: 60 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis
- Progressive Pulmonary Fibrosis

## Interventions

- **DRUG:** Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment

## Key facts

- **NCT ID:** NCT05241275
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-19
- **Primary completion:** 2025-11-03
- **Final completion:** 2026-08-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05241275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05241275, "Xenon MRI and Progressive ILD". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05241275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*